Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock
about
Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusionHigh mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptorHMGB1: endogenous danger signalingInflammatory mediators in intra-abdominal sepsis or injury - a scoping reviewHMGB1 mediates endogenous TLR2 activation and brain tumor regressionA dynamic view of trauma/hemorrhage-induced inflammation in mice: principal drivers and networksTargeting HMGB1 in inflammationResveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1Augmenter of liver regeneration (ALR) is a novel biomarker of hepatocellular stress/inflammation: in vitro, in vivo and in silico studiesRelease of endo-lysosomal cathepsins B, D, and L from IEC6 cells in a cell culture model mimicking intestinal manipulationBench-to-bedside review: latest results in hemorrhagic shockAlarmins: awaiting a clinical responseHemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2.Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion.Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation.High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans.DAMPening inflammation by modulating TLR signalling.Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury.Sequestering HMGB1 via DNA-conjugated beads ameliorates murine colitisRinger's lactate improves liver recovery in a murine model of acetaminophen toxicity.High mobility group B1 impairs hepatocyte regeneration in acetaminophen hepatotoxicityComplement factor 3 deficiency attenuates hemorrhagic shock-related hepatic injury and systemic inflammatory response syndrome.Up-regulated HMGB1 in EAM directly led to collagen deposition by a PKCβ/Erk1/2-dependent pathway: cardiac fibroblast/myofibroblast might be another source of HMGB1High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity.HMGB1 contributes to kidney ischemia reperfusion injury.Toll-like receptor 4 regulates platelet function and contributes to coagulation abnormality and organ injury in hemorrhagic shock and resuscitation.The acute inflammatory response in trauma / hemorrhage and traumatic brain injury: current state and emerging prospects.DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma.Anti-HMGB1 monoclonal antibody ameliorates immunosuppression after peripheral tissue trauma: attenuated T-lymphocyte response and increased splenic CD11b (+) Gr-1 (+) myeloid-derived suppressor cells require HMGB1.Translational systems approaches to the biology of inflammation and healing.HMGB1 neutralization is associated with bacterial translocation during acetaminophen hepatotoxicity.Poly(ADP-ribose) polymerase 1-sirtuin 1 functional interplay regulates LPS-mediated high mobility group box 1 secretion.Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammationHemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells.Mast cells play a critical role in the systemic inflammatory response and end-organ injury resulting from traumaGlycyrrhizin suppresses the expressions of HMGB1 and relieves the severity of traumatic pancreatitis in rats.Intestinal Epithelial TLR-4 Activation Is Required for the Development of Acute Lung Injury after Trauma/Hemorrhagic Shock via the Release of HMGB1 from the GutDisruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
P2860
Q21144322-B114ADEC-5365-4635-9A33-2A5B02E941E1Q24604370-57FEB140-CCD4-43B6-9E2A-53E68CF3CC33Q24645232-CFC743F4-2C5F-4BB2-8917-840144F751F3Q26778888-E203E3F4-2FF1-4668-9433-31D686C35D54Q27307459-0D95C9C5-152A-48C5-90BA-990752D6D247Q27343485-B2585EAA-B139-4F35-B48C-C3BB9A36C17DQ28266138-4DADCAC4-AA03-4B25-B44B-76A948F28D35Q28567865-B13A1F99-8AF4-410F-91C4-1359644BA973Q28575374-B1FEC3E7-35AB-49B0-AB42-B0CCD3212F91Q28579509-F39C5EB3-7DA2-4EED-8740-68D5B3E84246Q30370791-8BE37B49-A8E0-4073-885C-1DEFC86874DEQ30523797-F1F7195E-37EC-4B02-9023-1896B4A1EB70Q33579223-2539E102-2D59-46F6-8417-31268BE17455Q33612700-7C43A50A-EAAB-48DA-9981-D65B84BB60C9Q33814903-01FADAD7-D9D1-4241-B8B8-14304ED4A980Q33829272-B51F9EFE-CBF7-449B-9565-0DF2218F8684Q33836853-6A019DD9-40BC-4163-9307-631A93CE481FQ33898219-16565397-E0CD-4C17-B9CB-0F97A08B5CBDQ34035570-C12992D9-92A2-4A68-B30D-ED7327BC874DQ34035581-E0DF57B5-501A-4B96-AB5D-5D37D27B3187Q34050559-199F69B2-CB06-43B8-A13A-B90A13D08751Q34074958-2C1DE1CE-3DF6-4E33-934B-67EF21620E7EQ34262481-7B893E62-F464-4023-BE1E-2CA90D3D84F0Q34305737-1085282A-DB37-47C7-B45E-198D52595B4EQ34336825-BB878554-F354-4120-A3FC-59F65098767BQ34400931-8B261124-4B50-4BD1-8D13-44424F4B9F0CQ34457038-9708134A-CC38-4A28-BE73-9A70DEBEB5F2Q34734986-A0A73F96-A5E5-4F23-A00E-5FEA63776777Q34736071-EBE073AE-663F-43E2-A6CE-818EAE45CB23Q34979970-D4283F30-F0DC-471E-9DC8-6938BF3E6322Q35076030-EF94CDF9-179A-4E0A-8AA1-87A1BA82266AQ35098770-09ED8B6C-DB53-4E7E-9C64-EB9D9BFF053BQ35141090-DCA51E04-85EA-43DE-9E43-4BD129050577Q35192798-3646F8C9-1B23-4F1B-91B7-5AE091FBDE5FQ35286840-9F0F2565-3718-4399-8E27-6CEE7EA10D17Q35402021-7B411203-B5D6-450F-81D5-703E7C977D81Q35490658-2C255298-0EDD-4D11-8929-05868CD994E1Q35534222-FBA6AD0E-3556-419A-9A4E-D92BEEDD87E2Q35562915-2EB657EA-FB1D-4444-8742-212F3D1F3900Q35745551-9D32717E-C834-40F0-8D3A-58C6ABCC6C59
P2860
Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Anti-HMGB1 neutralizing antibo ...... rvival after hemorrhagic shock
@ast
Anti-HMGB1 neutralizing antibo ...... rvival after hemorrhagic shock
@en
type
label
Anti-HMGB1 neutralizing antibo ...... rvival after hemorrhagic shock
@ast
Anti-HMGB1 neutralizing antibo ...... rvival after hemorrhagic shock
@en
prefLabel
Anti-HMGB1 neutralizing antibo ...... rvival after hemorrhagic shock
@ast
Anti-HMGB1 neutralizing antibo ...... rvival after hemorrhagic shock
@en
P2093
P2860
P50
P356
P1433
P1476
Anti-HMGB1 neutralizing antibo ...... rvival after hemorrhagic shock
@en
P2093
Brian G Harbrecht
Jose M Prince
LiHong Yang
Margot Gallowitsch-Puerta
Mitchell P Fink
Runkuan Yang
Ryan M Levy
Timothy R Billiar
Tomoyuki Harada
P2860
P2888
P304
P356
10.2119/2006-00010.YANG
P407
P577
2006-04-01T00:00:00Z
P6179
1068964919